Baxter International Reports $1.13B Q4 Loss, Shares Plunge 16% Amid EPS Miss and Board Changes

Baxter International announced a significant fourth-quarter loss of $1.13 billion, which, coupled with adjusted earnings per share (EPS) of 44 cents falling below market expectations, led to a sharp 16% decline in its shares. The medical products company's financial performance overshadowed its revenue, which reportedly exceeded estimates. In corporate governance news, Baxter also appointed Michael R. McDonnell to its Board of Directors, effective February 13, 2026. This strategic board addition comes as the company navigates a challenging financial period. The substantial net loss and the miss on adjusted EPS were the primary drivers behind the negative market reaction. Investors are closely monitoring the company's future strategies following these developments.